TrialInvestigational new drugs2019

Absorption, metabolism, and excretion of the antiemetic rolapitant, a selective neurokinin-1 receptor antagonist, in healthy male subjects.

Zhi-Yi Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.